SCHEMBL712947

SCHEMBL712947

Cc1ccc(-c2ccccc2CBr)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.44
DPP4 P27487 1/20 0.42
FFAR1 O14842 2/20 0.41
FFAR4 Q5NUL3 2/20 0.41
PDCD1 Q15116 1/20 0.41
CD274 Q9NZQ7 1/20 0.41
RAB9A P51151 4/20 0.40
KMT2A Q03164 4/20 0.40
NPC1 O15118 3/20 0.40
MEN1 O00255 3/20 0.40
SYK P43405 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPK1 P28482 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28961512 0.87 DPP4 (0.48) HTR7DPP4PDCD1CD274KMT2A
SCHEMBL471 0.82 DPP4 (0.60) HTR7DPP4PDCD1CD274KMT2A
SCHEMBL31163822 0.82 DPP4 (0.60) HTR7DPP4PDCD1CD274KMT2A
SCHEMBL1309773 0.81 ALDH1A1 (0.48) DPP4FFAR1FFAR4PDCD1CD274
SCHEMBL29655972 0.81 TRPA1 (0.46) HTR7DPP4FFAR1FFAR4PDCD1
SCHEMBL7934930 0.81 TRPA1 (0.46) HTR7DPP4FFAR1FFAR4PDCD1
SCHEMBL812762 0.81 PDCD1 (0.57) HTR7DPP4FFAR1FFAR4PDCD1
SCHEMBL2902236 0.80 DPP4 (0.58) HTR7DPP4PDCD1CD274KMT2A
SCHEMBL10821219 0.79 HTR7 (0.44) HTR7DPP4FFAR1FFAR4PDCD1
SCHEMBL7016124 0.79 HTR7 (0.44) HTR7DPP4FFAR1FFAR4PDCD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK HTR7 2363/4885DPP4 37/4885FFAR1 3394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.